PeproTech Inc.
Originally published online as doi:10.1189/jlb.0905541 on October 23, 2006

Published online before print October 23, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0905541v1
81/1/238    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, X. J.
Right arrow Articles by Stasia, M.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, X. J.
Right arrow Articles by Stasia, M.-J.
(Journal of Leukocyte Biology. 2007;81:238-249.)
© 2007 by Society for Leukocyte Biology

Leu505 of Nox2 is crucial for optimal p67phox-dependent activation of the flavocytochrome b558 during phagocytic NADPH oxidase assembly

Xing Jun Li*, Franck Fieschi{dagger}, Marie-Hélène Paclet*, Didier Grunwald{ddagger}, Yannick Campion*, Philippe Gaudin*, Françoise Morel* and Marie-José Stasia*,1

* Groupe de Recherche et d’Etude du Processus Inflammatoire, Université Joseph Fourier, Laboratoire d’Enzymologie, Centre Hospitalier Universitaire, Grenoble, France;
{dagger} Institut de Biologie Structurale, CEA/CNRS/Université Joseph Fourier, Laboratoire des Proteines Membranaires, Grenoble, France; and
{ddagger} Département Réponse et Dynamique Cellulaire/Commissariat à l’Energie Atomique, Grenoble, France

1Correspondence: GREPI, EA UJF Laboratoire d’Enzymologie, Grenoble CHU 38043, Cedex 9, France. E-mail mjstasia{at}chu-grenoble.fr

The role of Leu505 of Nox2 on the NADPH oxidase activation process was investigated. An X-CGD PLB-985 cell line expressing the Leu505Arg Nox2 mutant was obtained, exactly mimicking the phenotype of a previously published X91+-CGD case. In a reconstituted cell-free system (CFS), NADPH oxidase and iodonitrotetrazolium (INT) reductase activities were partially maintained concomitantly with a partial cytosolic factors translocation to the plasma membrane. This suggests that assembly and electron transfer from NADPH occurred partially in the Leu505Arg Nox2 mutant. Moreover, in a simplified CFS using purified mutant cytochrome b558 and recombinant p67phox, p47phox, and Rac1proteins, we found that the Km for NADPH and for NADH was about three times higher than those of purified WT cytochrome b558, indicating that the Leu505Arg mutation induces a slight decrease of the affinity for NADPH and NADH. In addition, oxidase activity can be extended by increasing the amount of p67phox in the simplified CFS assay. However, the maximal reconstituted oxidase activity using WT purified cytochrome b558 could not be reached using mutant cytochrome b558. In a three-dimensional model of the C-terminal tail of Nox2, Leu505 appears to have a strategic position just at the entry of the NADPH binding site and at the end of the {alpha}-helical loop (residues 484–504), a potential cytosolic factor binding region. The Leu505Arg mutation seems to affect the oxidase complex activation process through alteration of cytosolic factors binding and more particularly the p67phox interaction with cytochrome b558, thus affecting NADPH access to its binding site.

Key Words: gp91phox • PLB-985 cells • X91+-CGD • {alpha}-helical loop • cytosolic C-terminal tail